National Health Research Institutes, Taiwan

This study tests a combination of two drugs, lenvatinib and paclitaxel, in people with advanced bile duct cancer that has stopped responding to standard chemotherapy. The goal is to see if this treatment can shrink tumors or slow the disease. About 51 adults with various types of…

This study compares two chemotherapy combinations for people with metastatic pancreatic cancer that has spread. The goal is to see which combo shrinks tumors better and helps people live longer without the cancer growing. About 66 adults will receive either gemcitabine, nab-pacli…

This study tests a combination of two drugs (atezolizumab and bevacizumab) in people with advanced liver cancer who also have chronic hepatitis B. The goal is to see if the treatment can shrink or control the cancer. Participants receive the drugs by IV and are monitored for side…

This study looks at the genetic makeup of a rare stomach cancer called GIST in 50 Taiwanese patients whose tumors lack the most common gene changes. By analyzing their DNA, researchers hope to find new treatment options for these hard-to-treat cases. The goal is to better underst…

This study aims to collect and analyze tumor tissue from 480 adults with advanced biliary tract cancer in Taiwan. By using genetic sequencing, researchers hope to identify key mutations that could guide personalized treatments and clinical trials. Participants must be 20 or older…